Figure 1.
Pharmacokinetic profiles. Mean plasma concentration profiles and SEM at euglycaemia (A) and at hypoglycaemia (B) after single subcutaneous doses of dasiglucagon and commercial glucagon (Eli Lilly)
Pharmacokinetic profiles. Mean plasma concentration profiles and SEM at euglycaemia (A) and at hypoglycaemia (B) after single subcutaneous doses of dasiglucagon and commercial glucagon (Eli Lilly)